The networks of the candidate proteins and the chemotherapy drugs showed a strong relationship with DNA topoisomerase II alpha (TOP2A), a biomarker of oral cancers (Fig. 6)43,44. This evidence concerns the gene TOP2A and lip and oral cavity carcinoma.